Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - leo wang
Delayed-Release Hydrogel for the Treatment of Intracranial Glioblastoma
A hydrogel-based implant enables sustained-release delivery of valproic acid for improved treatment of intracranial glioblastoma. Problem: Glioblastoma is the most common primary malignant brain tumor, accounting for 52 percent of all primary brain tumors, and is typically fatal within 15 months after diagnosis. Standard treatment involves tumor...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by